How to Get Synthroid (Levothyroxine) in South Dakota

What Is Levothyroxine and Why Is It Prescribed?

Levothyroxine is a synthetic form of the thyroid hormone T4. It is the first-line treatment for primary hypothyroidism, the condition in which the thyroid gland produces insufficient hormone. The drug is identical in structure to endogenous thyroxine and restores normal metabolic function when the gland fails.

The American Thyroid Association (ATA) 2014 guidelines state: "Levothyroxine (L-T4) should be used as the standard of care for the treatment of hypothyroidism." [1] Those guidelines, authored by Jonklaas et al. and published in Thyroid, remain the benchmark reference for every prescriber in the country, including South Dakota clinicians.

Synthroid is the original branded formulation, manufactured by AbbVie. [2] Generic levothyroxine tablets from manufacturers including Mylan, Lannett, and Amneal carry FDA approval and are therapeutically equivalent for most patients when the same manufacturer's product is used consistently. [3] The FDA has designated levothyroxine a narrow therapeutic index (NTI) drug, meaning small changes in absorption can shift TSH outside the target range. [4]

Primary hypothyroidism affects approximately 4.6% of the U.S. population aged 12 and older based on data from the National Health and Nutrition Examination Survey. [5] South Dakota's rural geography means a substantial share of patients have historically traveled long distances for thyroid care, making telehealth access particularly relevant.

Who Can Prescribe Synthroid in South Dakota?

Any licensed prescriber with authority to issue Schedule and non-controlled prescriptions in South Dakota may prescribe levothyroxine. That includes MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs).

South Dakota grants NPs full practice authority under SDCL 36-9A, meaning a nurse practitioner does not need physician oversight to prescribe levothyroxine. [6] PAs in South Dakota must maintain a collaboration agreement, but that agreement does not restrict which drugs they may prescribe. Telehealth prescribers licensed in another state who hold a valid South Dakota license or registration may also prescribe under the state's telehealth statutes. [7]

South Dakota joined the Interstate Medical Licensure Compact (IMLC), which allows physicians licensed in other compact states to obtain expedited South Dakota licensure. [8] The Nurse Licensure Compact (NLC) allows multistate NP practice in South Dakota without a separate state license for nurses already holding a compact license. [9] Both pathways directly expand the pool of clinicians available to South Dakota telehealth patients seeking levothyroxine.

Labs Required Before Synthroid Is Prescribed

A serum TSH measurement is the minimum required test before initiating levothyroxine. TSH is the most sensitive marker of thyroid function and is used both to confirm hypothyroidism and to establish a baseline for dose titration. [1]

A free T4 (FT4) level is typically ordered alongside TSH. FT4 confirms whether the elevated TSH reflects overt hypothyroidism (low FT4) or subclinical hypothyroidism (normal FT4). The ATA guidelines recommend treating overt hypothyroidism (TSH above the laboratory reference range with a low FT4) in virtually all adults. [1] Subclinical hypothyroidism (TSH above reference with normal FT4) is treated selectively based on TSH level, symptoms, cardiovascular risk, and patient age. [10]

Additional labs a South Dakota clinician may order include:

• Thyroid peroxidase antibodies (TPOAb): Positive results confirm Hashimoto thyroiditis, the most common cause of hypothyroidism in the U.S. [11]
• Complete metabolic panel (CMP): Checks for comorbid conditions that affect levothyroxine dosing, such as hepatic or renal disease.
• Lipid panel: Hypothyroidism elevates LDL cholesterol; a baseline is useful to track treatment response. [12]
• CBC: Ordered selectively if anemia or another systemic cause is suspected.

Most commercial labs in South Dakota can return TSH and FT4 results within 24 to 48 hours. Telehealth platforms that operate in South Dakota commonly partner with national lab networks (LabCorp, Quest Diagnostics) that have draw sites in cities including Sioux Falls, Rapid City, Aberdeen, and Watertown.

How to Get a Synthroid Prescription in South Dakota: Step by Step

Getting levothyroxine in South Dakota follows a defined sequence regardless of whether the appointment is in person or via telehealth.

Step 1. Schedule an appointment. Book with a primary care physician, endocrinologist, NP, or PA in South Dakota, or with a telehealth platform licensed to prescribe in South Dakota. HealthRX connects patients with licensed clinicians who can evaluate thyroid function and issue prescriptions in all states where telehealth prescribing is permitted, including South Dakota.

Step 2. Complete lab work. Order or present a TSH result dated within the past six months. Some prescribers accept a recent outside result; others require a new draw through their affiliated lab network.

Step 3. Attend the clinical visit. The clinician reviews your symptoms (fatigue, cold intolerance, weight gain, constipation, dry skin, cognitive slowing), lab values, medication list, and relevant history including prior thyroid surgery, radioactive iodine treatment, or neck radiation. [1]

Step 4. Receive the prescription. In South Dakota, levothyroxine prescriptions may be transmitted electronically to any in-state or mail-order pharmacy. There is no controlled-substance designation, so no special prescribing forms are required. [13]

Step 5. Fill at a licensed pharmacy. South Dakota retail pharmacies and mail-order pharmacies licensed by the South Dakota Board of Pharmacy may dispense the prescription. A 90-day supply is commonly available via mail order. [14]

Step 6. Recheck TSH in 4 to 8 weeks. The ATA recommends rechecking TSH four to eight weeks after initiating therapy or changing dose. [1] Most telehealth platforms support a follow-up lab order at the time of the initial visit.

Telehealth Options for Synthroid in South Dakota

South Dakota permits telehealth prescribing of levothyroxine, and no in-person visit is required before a clinician may issue the prescription. The state's telehealth parity law (SDCL 58-17-118) requires most commercial insurers to reimburse telehealth visits at the same rate as in-person visits for services that are covered. [7]

A valid prescriber-patient relationship must still be established. South Dakota follows the American Medical Association guidance that a telehealth encounter is sufficient to form a valid prescriber-patient relationship when the clinician conducts a real-time audio-visual evaluation and reviews the patient's medical and drug history. [15] Asynchronous (store-and-forward) visits without live interaction may not satisfy this requirement under current South Dakota interpretation, though this is evolving.

Platforms operating in South Dakota must ensure the prescribing clinician holds a valid South Dakota license or a multistate compact license that includes South Dakota. Prescriptions issued by out-of-state clinicians who lack South Dakota licensure are not valid at South Dakota pharmacies. [14]

HealthRX Telehealth Levothyroxine Access Framework for South Dakota

The table below summarizes the three pathways a South Dakota patient may use to obtain levothyroxine, with the key requirements for each.

| Pathway | Prescriber Type | In-Person Required | Lab Required Before Rx | Typical Time to Rx | |---|---|---|---|---| | In-person primary care | MD / DO / NP / PA | Yes | Yes (TSH) | Same day | | In-person endocrinology | MD / DO | Yes | Yes (TSH + FT4) | Same day (may require wait for specialist appt) | | Telehealth (audio-visual) | MD / DO / NP / PA (SD licensed) | No | Yes (TSH within 6 months) | 1 to 3 business days |

Synthroid at South Dakota Pharmacies

Levothyroxine is stocked at virtually every retail pharmacy chain and independent pharmacy in South Dakota. Major chains operating in the state include Walgreens, CVS, Hy-Vee Pharmacy, Lewis Drug, and Walmart Pharmacy. Mail-order options through Express Scripts, OptumRx, and Costco Pharmacy are also available to South Dakota residents.

Because the FDA classifies levothyroxine as an NTI drug, the South Dakota Board of Pharmacy recommends that patients not switch between manufacturers without consulting their prescriber. [4] A brand-to-generic switch, or a switch between generic manufacturers, can shift the plasma T4 area under the curve by as much as 12.5%, which may move TSH outside the target range in sensitive patients. [16]

Synthroid 100 mcg (a common mid-range dose) has a retail cash price of approximately $30 to $50 for a 30-day supply at South Dakota pharmacies; generic levothyroxine 100 mcg costs $4 to $15 for the same supply depending on the pharmacy and discount card used. GoodRx coupons accepted at South Dakota pharmacies routinely bring the generic below $10. [17]

South Dakota Medicaid does not cover Synthroid (brand) as of the current formulary. Generic levothyroxine may be covered under the South Dakota Medicaid preferred drug list. Patients should verify current formulary status with South Dakota Department of Social Services before assuming coverage. [18]

503A Compounding Pharmacies and Levothyroxine in South Dakota

A 503A pharmacy is a traditional compounding pharmacy that prepares medications for individual patients based on a valid prescription. South Dakota-licensed 503A compounding pharmacies may compound levothyroxine in dosage forms or strengths not commercially available, such as specific doses for patients with dye allergies (commercial Synthroid tablets contain synthetic dyes) or patients who require liquid formulations. [19]

503A compounding pharmacies in South Dakota must be licensed by the South Dakota Board of Pharmacy and comply with USP Chapter 795 standards for non-sterile compounding. [20] They may also compound desiccated thyroid extract (DTE) formulations for patients whose prescribers have documented a medical need. Compounded thyroid products are not FDA-approved and should be used only when a commercially available product is inadequate. [19]

Some patients with Hashimoto thyroiditis or persistent symptoms on standard levothyroxine ask about combination T4/T3 therapy. The ATA 2014 guidelines note that evidence does not support routine combination therapy but acknowledge it may be appropriate in select cases. [1] If a clinician determines that a compounded T4/T3 combination is indicated, a South Dakota 503A pharmacy can prepare it. The FDA does not approve compounded products, and quality and potency may vary between compounding facilities. [21]

Transferring an Existing Synthroid Prescription to South Dakota

Patients relocating to South Dakota or temporarily living in the state may transfer an existing levothyroxine prescription from an out-of-state pharmacy to a South Dakota pharmacy. Federal law and South Dakota pharmacy rules permit the transfer of non-controlled substance prescriptions between licensed pharmacies for any remaining refills. [13]

To transfer a prescription:

1. Contact the South Dakota pharmacy where you want to fill the prescription.
2. Provide the original pharmacy's name and phone number along with your date of birth and the drug name and strength.
3. The receiving South Dakota pharmacist contacts the dispensing pharmacy and records the transfer.

South Dakota law allows the original pharmacy to transfer the prescription only once. After transfer, the original pharmacy can no longer dispense that prescription. If refills run out, a new prescription is required from a South Dakota-licensed prescriber or a prescriber with South Dakota prescribing authority. [14]

Patients who have recently moved to South Dakota and whose prescriptions are expiring should schedule a telehealth or in-person visit promptly. A new TSH drawn in South Dakota provides the new prescriber with a current baseline and confirms that the existing dose remains appropriate. Dose requirements can shift with age, body weight changes, pregnancy, and concurrent medication use, so a new clinical evaluation is clinically appropriate even if the patient has been stable for years. [1]

Prior Authorization for Synthroid in South Dakota

Brand-name Synthroid requires prior authorization (PA) from most South Dakota commercial health plans. Generic levothyroxine is on the preferred tier of most formularies without PA. A prescriber pursuing brand Synthroid for a patient on a plan requiring PA must typically document:

• Medical necessity for brand over generic (for example, documented TSH instability on generic with confirmed same-manufacturer supply)
• One or more therapeutic failures or intolerances on generic levothyroxine
• Clinical notes supporting the brand as medically necessary

South Dakota's largest commercial payers, including Wellmark Blue Cross Blue Shield of South Dakota and Sanford Health Plan, follow this general framework. Medicaid managed care organizations operating in South Dakota follow the South Dakota Department of Social Services preferred drug list. [18]

The prescriber's office typically submits the PA request electronically through the plan's portal or via fax. Standard PA turnaround is 72 hours for non-urgent requests; urgent requests must be processed within 24 hours under ACA regulations. [22] If the PA is denied, the prescriber may file an appeal or request a peer-to-peer review with the plan's medical director.

Patients who cannot obtain brand coverage may ask their prescriber to document a single-manufacturer preference on the generic prescription, for example "dispense Mylan levothyroxine only." South Dakota pharmacies are not legally required to honor manufacturer-specific requests, but many will accommodate them when the request is noted on the prescription. [14]

Dosing, Titration, and Monitoring in South Dakota Patients

The standard starting dose of levothyroxine in otherwise healthy adults younger than 65 without cardiac disease is 1.6 mcg/kg/day, rounded to the nearest available tablet strength. [1] Common tablet strengths available in South Dakota pharmacies range from 25 mcg to 300 mcg (25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 to 300 mcg). [2]

In adults over 65 or in patients with known or suspected coronary artery disease, most clinicians start at 25 to 50 mcg/day and increase by 12.5 to 25 mcg increments every four to six weeks to reduce the risk of precipitating angina or arrhythmia. [1] The ATA guideline states: "In the elderly and in patients with known cardiovascular disease, the initial daily dose of L-T4 should be lower than the full replacement dose." [1]

TSH should be rechecked four to eight weeks after each dose adjustment. The TSH target range for most adults is 0.4 to 4.0 mIU/L. For patients treated for differentiated thyroid cancer, TSH suppression targets are individualized based on recurrence risk; low-risk patients may target 0.5 to 2.0 mIU/L while high-risk patients may target below 0.1 mIU/L. [23]

Drug interactions that affect levothyroxine absorption are common and relevant to dosing. Calcium carbonate, ferrous sulfate, cholestyramine, sucralfate, proton pump inhibitors, and certain antacids all reduce levothyroxine absorption when taken concurrently. [24] Patients should take levothyroxine 30 to 60 minutes before breakfast or at least four hours apart from these agents. [2]

Pregnancy requires prompt dose adjustment. TSH targets during pregnancy are trimester-specific, with a first-trimester target of 0.1 to 2.5 mIU/L per the ATA. [25] South Dakota OB and maternal-fetal medicine clinicians routinely check TSH at the first prenatal visit; women on levothyroxine at conception should contact their prescriber immediately upon a positive pregnancy test, as the dose typically needs to increase by 20 to 30% within the first trimester. [25]

Special Populations in South Dakota

South Dakota has a significant Native American population served in part by Indian Health Service (IHS) facilities. IHS facilities prescribe and dispense levothyroxine under federal formulary rules, which include generic levothyroxine as a covered drug. Patients receiving care at IHS sites in South Dakota (including facilities in the Cheyenne River, Crow Creek, Flandreau, Lower Brule, Oglala Sioux, Rosebud, Sisseton-Wahpeton, Standing Rock, and Yankton Sioux service areas) should confirm formulary coverage with their IHS pharmacist. [26]

Rural South Dakota patients who live far from a pharmacy may benefit from mail-order dispensing. The Center for Connected Health Policy notes that telehealth use in frontier and rural states has grown sharply since 2020, and South Dakota's rural broadband expansion has increased the practical availability of audio-visual telehealth visits. [27] Patients with limited broadband access may use telephone-only visits in some circumstances, though audio-visual visits are preferred for initial levothyroxine prescribing.

Elderly patients in long-term care facilities in South Dakota receive medications through consultant pharmacists and institutional pharmacies. The Omnibus Reconciliation Act and South Dakota long-term care pharmacy rules require monthly medication regimen reviews; levothyroxine dose appropriateness is commonly assessed in this review given the frequency of hypothyroidism in older adults. [28]

Absorption, Administration, and Patient Instructions

Levothyroxine absorption drops by 40% or more when taken with food. [24] Patients should take the tablet on an empty stomach, 30 to 60 minutes before any food, coffee, or other medications. Taking levothyroxine at bedtime (at least three hours after the last meal) is an alternative supported by data showing slightly improved TSH suppression in some patients. [29]

Tablets should not be crushed and mixed with high-calcium foods such as soy milk or calcium-fortified juice. For patients who cannot swallow tablets, a liquid levothyroxine formulation (Tirosint-SOL) is FDA-approved and eliminates absorption concerns related to tablet excipients. [30] South Dakota pharmacies that do not stock Tirosint-SOL can order it through their wholesaler or a patient may use mail-order.

The TSH recheck interval of four to eight weeks is non-negotiable. [1] Patients who feel well at week three should still complete the follow-up lab before any dose change is considered.